Crumly & Associates Inc. Merck & Co., Inc. Transaction History

Crumly & Associates Inc.

$318 Million
Q3 2024

A detailed history of Crumly & Associates Inc. transactions in Merck & Co., Inc. stock. As of the latest transaction made, Crumly & Associates Inc. holds 8,290 shares of MRK stock, worth $800,316. This represents 0.3% of its overall portfolio holdings.

Number of Shares

8,290

Previous 7,626 8.71%

Holding current value

$800,316

Previous $944,000 0.32%

% of portfolio

0.3%

Previous 0.3%

20 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 01, 2024	BUY	$111.15 - $128.97 $73,803 - $85,636	664 Added 8.71%	8,290 $941,000
Q2 2024 Aug 02, 2024	SELL	$123.8 - $132.96 $8,047 - $8,642	-65 Reduced 0.85%	7,626 $944,000
Q1 2024 May 01, 2024	BUY	$113.24 - $131.95 $6,228 - $7,257	55 Added 0.72%	7,691 $1.01 Million
Q4 2023 Jan 29, 2024	BUY	$100.18 - $109.02 $1,502 - $1,635	15 Added 0.2%	7,636 $832,000
Q4 2023 Jan 29, 2024	BUY	$100.18 - $109.02 $94,970 - $103,350	948 Added 14.21%	7,621 $830,000
Q3 2023 Nov 02, 2023	BUY	$102.95 - $114.33 $40,047 - $44,474	389 Added 6.19%	6,673 $686,000
Q2 2023 Jul 21, 2023	SELL	$108.61 - $118.38 $120,122 - $130,928	-1,106 Reduced 14.97%	6,284 $725,000
Q1 2023 Apr 24, 2023	BUY	$102.94 - $114.86 $51,058 - $56,970	496 Added 7.19%	7,390 $786,000
Q4 2022 Mar 03, 2023	SELL	$87.44 - $112.11 $14,165 - $18,161	-162 Reduced 2.3%	6,894 $764,000
Q3 2022 Oct 25, 2022	SELL	$84.53 - $94.96 $8,706 - $9,780	-103 Reduced 1.44%	7,056 $607,000
Q2 2022 Aug 01, 2022	SELL	$83.49 - $94.64 $62,367 - $70,696	-747 Reduced 9.45%	7,159 $653,000
Q1 2022 May 02, 2022	BUY	$73.51 - $82.4 $47,855 - $53,642	651 Added 8.97%	7,906 $648,000
Q4 2021 Feb 04, 2022	SELL	$72.28 - $90.54 $534,799 - $669,905	-7,399 Reduced 50.49%	7,255 $573,000
Q3 2021 Oct 20, 2021	BUY	$71.68 - $78.83 $243,855 - $268,179	3,402 Added 30.23%	14,654 $1.1 Million
Q2 2021 Aug 09, 2021	BUY	$70.31 - $77.77 $329,472 - $364,430	4,686 Added 71.37%	11,252 $875,000
Q1 2021 Apr 27, 2021	BUY	$68.86 - $81.11 $45,378 - $53,451	659 Added 11.16%	6,566 $506,000
Q4 2020 Jan 25, 2021	SELL	$71.77 - $79.65 $90,645 - $100,597	-1,263 Reduced 17.62%	5,907 $478,000
Q3 2020 Oct 21, 2020	BUY	$73.18 - $82.95 $39,736 - $45,041	543 Added 8.19%	7,170 $567,000
Q2 2020 Jul 07, 2020	BUY	$70.42 - $80.13 $199,640 - $227,168	2,835 Added 74.76%	6,627 $512,000
Q1 2020 Apr 21, 2020	BUY	$63.36 - $87.82 $240,261 - $333,013	3,792 New	3,792 $292,000

Others Institutions Holding MRK

# of Institutions

3,820

Shares Held

1.88B

Call Options Held

15.6M

Put Options Held

13.7M

View Full List

About Merck & Co., Inc.

Ticker MRK
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,533,280,000
Market Cap $245B
Description
Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, ...

More about MRK

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Crumly & Associates Inc., based on Form 13F filings with the SEC.

News

Stay updated on Crumly & Associates Inc. with notifications on news.

Account

Crumly & Associates Inc. Merck & Co., Inc. Transaction History